Companion Animals

Dog Canine Atopy Immunotherapy: Long-Term Welfare Outcomes

Allergen-specific immunotherapy for atopic dogs offers the potential for sustained welfare improvement beyond medication management.

Key Facts

Allergen immunotherapy achieves partial or full remission in 50-80% of treated dogs over 1-2 years
Treatment requires weekly injections or sublingual drops for 1-2 years before maximum benefit
Dogs in remission may need reduced or no ongoing medication, reducing side effect burden
Specific allergy testing is required before immunotherapy to identify relevant allergens

Welfare Considerations

Allergen immunotherapy modifies the immune response rather than merely suppressing symptoms. Dogs achieving remission experience sustained reduction in itch and skin disease without ongoing high-dose medication side effects. The two-year commitment is a welfare investment with lasting returns.

What You Can Do

Consult a veterinary dermatologist for specific allergy testing before immunotherapy
Commit to the full immunotherapy protocol - partial courses produce reduced benefit
Track itch scores and skin condition during immunotherapy to assess progress